Tag Archives: Voyager Therapeutics

Oppenheimer Initiates a Buy Rating on Voyager Therapeutics (VYGR)

In a report released today, Jay Olson from Oppenheimer initiated coverage with a Buy rating on Voyager Therapeutics (VYGR – Research Report) and a price target of $26.00. The company’s shares closed last Monday at $12.62, close to its 52-week

Evercore ISI Keeps a Hold Rating on Voyager Therapeutics (VYGR)

Evercore ISI analyst Joshua Schimmer maintained a Hold rating on Voyager Therapeutics (VYGR – Research Report) on November 22 and set a price target of $18.00. The company’s shares closed last Monday at $14.26. According to TipRanks.com, Schimmer is a

Voyager Therapeutics (VYGR) Receives a Buy from Cowen & Co.

In a report released today, Phil Nadeau from Cowen & Co. maintained a Buy rating on Voyager Therapeutics (VYGR – Research Report). The company’s shares closed last Monday at $14.66. According to TipRanks.com, Nadeau is a 4-star analyst with an